Clinical Trial Update: 68Ga-DOTATATE PET-CTA Imaging for the Early Detection of Progressing Coronary Atherosclerosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating 68Ga-DOTATATE PET-CTA imaging for early detection of progressing coronary arteriosclerosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Arteriosclerosis

Drugs mentioned

• 68Ga-DOTATATE (Gallium-68 DOTATATE)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Coronary Arteriosclerosis | Phase 3 | Status: TERMINATED